Work in mice has led to the hypothesis that levels of cardiolipin, a phospholipid component of mitochondrial membranes, impact cardiac function. In Drosophila, the role of cardiolipin synthase (CLS, orthologous to the human gene CRLS1) in cardiac function has been assessed. A number of genetic reagents have been generated for Dmel\CLS including RNAi-targeting constructs and alleles caused by insertional mutagenesis.
The human CRLS1 gene has not been introduced into flies. CRLS1 is implicated in a severe disease, combined oxidative phosphorylation deficiency 57 (MIM:620167); cardiac dysfunction is frequently observed in patients with this disease.
Assessed in adult flies, RNAi-mediated cardiomyocyte-specific knockdown of CLS results in cardiac dilation, impairment of systolic performance, and an increase in arrhythmic events.
[updated Apr. 2024 by FlyBase; FBrf0222196]
CRLS1 encodes a member of the CDP-alcohol phosphatidyltransferase class-I family of proteins. The encoded enzyme catalyzes the synthesis of cardiolipin, a phospholipid component of mitochondrial membranes that is critical for mitochondrial function. [Gene Cards, CRLS1; 2021.12.19]
One to one: 1 human gene to 1 Drosophila gene.
High-scoring ortholog of human CRLS1 (1 Drosophila to 1 human). Dmel\CLS shares 48% identity and 69% similarity with the human gene.